Remove 2009 Remove Patients Remove Prescription
article thumbnail

The current pricing of cancer treatments is unsustainable

World of DTC Marketing

From 2009 to 2019, the median monthly treatment costs for new drugs at launch reached $11,755 in the U.S… From 2009-10 to 2018-19, the lowest average monthly costs for new cancer drugs approved by the U.S. Rapamycin was approved in 1999 and it’s also worth noting their Phase II was a tiny patient population.

article thumbnail

Drug side effects should be easier to understand

World of DTC Marketing

SUMMARY: Per the Times, “what if consumers could calculate the benefits and risks of taking a prescription drug as easily as they can gauge the carbohydrates and calories in an Oreo cookie?” According to the AMA one of the key reasons for non-adherence is that patients may be frightened of potential side effects.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

You can’t afford to get cancer

World of DTC Marketing

OPENING: American cancer patients spent more than $21 billion on their care in 2019. billion and patient time costs of $4.87 Some cancer patients may face out-of-pocket costs of nearly $12,000 a year for one drug. Many cancer patients without adequate insurance have only the starkest choice: your money or your life.

article thumbnail

The current pharma business model is unsustainable

World of DTC Marketing

In pharma, growth depends on new products with hefty price tags when over 80% of voters want lower costs for their prescription drugs. While that sounds encouraging, most cancer drugs launched between 2009 and 2014 cost more than USD 100,000 annually. Biogen’s failure should be a warning to other pharma companies.

Pharma 210
article thumbnail

Common sense approach to the pharma industry

World of DTC Marketing

Pharma companies are still too focused on profits while people continue to rely on prescription drugs to compensate for unhealthy lifestyles. I understand the hard-working people who really believe in what they’re doing for patients, but senior executives continue to bow to Wall Street. Are prescription drugs priced too high?

Pharma 155
article thumbnail

What the latest DEA Proposed Rule Means for Telemedicine Prescribing of Controlled Substances

Nixon Gwilt Law

Notably, this rulemaking does not propose to implement the “special registration” for telemedicine providers the DEA has been promising since the Ryan Haight Act passed in 2009. Instead, it would create a new regulatory category of the “practice of telemedicine.”

article thumbnail

Thursday pharma headlines

World of DTC Marketing

prescriptions of finasteride, as the drug is known, for hair loss increased to over 2.4 As early as 2009, Merck knew of more than 200 reports of depression, including suicidal thoughts, in men taking Propecia, according to an internal “risk management” assessment from that year. Newly unsealed court documents show that Merck and U.S.

Pharma 180